- Home
- CUE vs FTHM Comparison
CUE vs FTHM Comparison
Compare CUE & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- FTHM
- Stock Information
- Founded
- CUE 2014
- FTHM 2010
- Country
- CUE United States
- FTHM United States
- Employees
- CUE N/A
- FTHM N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- FTHM Real Estate
- Sector
- CUE Health Care
- FTHM Finance
- Exchange
- CUE Nasdaq
- FTHM Nasdaq
- Market Cap
- CUE 48.0M
- FTHM 33.6M
- IPO Year
- CUE 2018
- FTHM 2020
- Fundamental
- Price
- CUE $0.78
- FTHM $1.24
- Analyst Decision
- CUE Strong Buy
- FTHM Buy
- Analyst Count
- CUE 3
- FTHM 1
- Target Price
- CUE $3.00
- FTHM $2.50
- AVG Volume (30 Days)
- CUE 273.1K
- FTHM 79.7K
- Earning Date
- CUE 08-13-2025
- FTHM 08-11-2025
- Dividend Yield
- CUE N/A
- FTHM N/A
- EPS Growth
- CUE N/A
- FTHM N/A
- EPS
- CUE N/A
- FTHM N/A
- Revenue
- CUE $7,991,000.00
- FTHM $357,816,000.00
- Revenue This Year
- CUE N/A
- FTHM $32.40
- Revenue Next Year
- CUE $23.84
- FTHM $18.04
- P/E Ratio
- CUE N/A
- FTHM N/A
- Revenue Growth
- CUE 13.83
- FTHM 5.80
- 52 Week Low
- CUE $0.45
- FTHM $0.65
- 52 Week High
- CUE $1.99
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- CUE 58.42
- FTHM 58.94
- Support Level
- CUE $0.65
- FTHM $1.24
- Resistance Level
- CUE $0.88
- FTHM $1.36
- Average True Range (ATR)
- CUE 0.07
- FTHM 0.08
- MACD
- CUE 0.02
- FTHM -0.01
- Stochastic Oscillator
- CUE 63.74
- FTHM 70.73
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.